Serum lipoprotein Lp(a) concentrations are not influenced by an HMG CoA reductase inhibitor
- 1 May 1988
- journal article
- eilige kurzmitteilung
- Published by Springer Science and Business Media LLC in Journal of Molecular Medicine
- Vol. 66 (10), 462-463
- https://doi.org/10.1007/bf01745519
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Teaching old dogmas new tricksNature, 1987
- Lovastatin (Mevinolin) in the Treatment of Heterozygous Familial HypercholesterolemiaAnnals of Internal Medicine, 1987
- cDNA sequence of human apolipoprotein(a) is homologous to plasminogenNature, 1987
- Structural Relationship of an Apolipoprotein (a) Phenotype (570 kDa) to Plasminogen: Homologous Kringle Domains are Linked by Carbohydrate-Rich RegionsBiological Chemistry Hoppe-Seyler, 1987
- The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis: Dependence on serum LDL levelsAtherosclerosis, 1986
- Mevinolin, an inhibitor of cholesterol synthesis, induces mRNA for low density lipoprotein receptor in livers of hamsters and rabbits.Proceedings of the National Academy of Sciences of the United States of America, 1986
- EFFECTS OF SYNVINOLIN (MK-733) ON PLASMA LIPIDS IN FAMILIAL HYPERCHOLESTEROLAEMIAThe Lancet, 1986
- Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.Circulation, 1986
- Levels of lipoprotein Lp(a) decline with neomycin and niacin treatmentAtherosclerosis, 1985
- Diverging effects of cholestyramine on apolipoprotein B and lipoprotein Lp(a): A dose-response study of the effects of cholestyramine in hypercholesterolaemiaAtherosclerosis, 1982